company background image
1FPB logo

Forward Pharma DB:1FPB Stock Report

Last Price

€1.76

Market Cap

€14.1m

7D

0%

1Y

-65.1%

Updated

02 Apr, 2023

Data

Company Financials

1FPB Stock Overview

Forward Pharma A/S does not have significant operations.

1FPB fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Forward Pharma A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Forward Pharma
Historical stock prices
Current Share PriceUS$1.76
52 Week HighUS$5.45
52 Week LowUS$1.47
Beta1.65
1 Month Change0%
3 Month Change1.15%
1 Year Change-65.15%
3 Year Change-63.64%
5 Year Change-85.87%
Change since IPO-98.37%

Recent News & Updates

Recent updates

Shareholder Returns

1FPBDE BiotechsDE Market
7D0%-0.9%-0.2%
1Y-65.1%-22.4%2.4%

Return vs Industry: 1FPB underperformed the German Biotechs industry which returned -23.1% over the past year.

Return vs Market: 1FPB underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is 1FPB's price volatile compared to industry and market?
1FPB volatility
1FPB Average Weekly Movementn/a
Biotechs Industry Average Movement5.2%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.3%
10% least volatile stocks in DE Market2.5%

Stable Share Price: 1FPB has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 1FPB's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20054Claus Bo Svendsenwww.forward-pharma.com

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Forward Pharma A/S Fundamentals Summary

How do Forward Pharma's earnings and revenue compare to its market cap?
1FPB fundamental statistics
Market cap€14.06m
Earnings (TTM)-€521.80k
Revenue (TTM)n/a

0.0x

P/S Ratio

-27.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1FPB income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$566.00k
Earnings-US$566.00k

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.08
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio4.7%

How did 1FPB perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.